TypeName: Business Offer
Country: United States
Summary: Ximelagatran, an ester prodrug of melagatran, with anticoagulant effect, is the first member of direct thrombin inhibitors that can be taken orally.
https://www.bocsci.com/ximelagatran-cas-192939-46-1-item-264384.html
Description: We leverage our wide spectrum of business in the fields of development, manufacturing, marketing, and distribution to help you make best-informed decisions tailored to your evolving needs for premium chemicals. Our complete suite of CRO services spans the entire molecule development pipeline including contract research for target identification, building blocks, compound synthesis, biochemical and cellular analysis, preclinical animal tests, and clinical studies.
OfferId: 2247
Name:Alex Brown
Telphone: